fig2

A baseline-lymphocyte-subset nomogram for predicting severe immune-related adverse events in hepatocellular carcinoma patients receiving TACE plus immunotherapy

Figure 2. Area under the ROC curve (AUC) for the nomogram predictive model. ROC: Receiver operating characteristic; NLR: neutrophil-to-lymphocyte ratio; Treg: regulatory T cell.

Hepatoma Research
ISSN 2454-2520 (Online) 2394-5079 (Print)

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/

Portico

All published articles are preserved here permanently:

https://www.portico.org/publishers/oae/